Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Lifeline CoTSE:7575 90 3-1 Month Momentum % is 17.37% as of Sep. 21, 2026. GuruFocus rates TSE:7575 with a GF Score™ of 90/100 and a GF Value™ of 円1,555.58 (Fairly Valued). The stock has 3 warning signs investors should review. Among 847 Medical Devices & Instruments companies, Japan Lifeline Co ranks better than 83.23% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-21), Japan Lifeline Co's 3-1 Month Momentum % is 17.37%.
The industry rank for Japan Lifeline Co's 3-1 Month Momentum % or its related term are showing as below:
TSE:7575's 3-1 Month Momentum % is ranked better than 83.23% of 847
companies
in the Medical Devices & Instruments industry
Industry Median: 0.61
vs TSE:7575: 17.37
Japan Lifeline Co (TSE:7575) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Japan Lifeline Co 3-1 Month Momentum % Related Terms
TSE:7575 vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Japan Lifeline Co's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's 3-1 Month Momentum % falls into.
Japan Lifeline Co (TSE:7575) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Lifeline Co (TSE:7575) has a 3-1 Month Momentum % of 17.37% as of Sep. 21, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Japan Lifeline Co and its competitors. According to the industry distribution chart, Japan Lifeline Co ranks #142 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 16.8%.
Is Japan Lifeline Co's 3-1 Month Momentum % too high?
Japan Lifeline Co's current 3-1 Month Momentum % is 17.37%. The Medical Devices & Instruments industry median 3-1 Month Momentum % is 0.61. Japan Lifeline Co's value of 17.37% is 2747.5% above this industry median. Based on the distribution chart, Japan Lifeline Co ranks #142 out of 847 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Japan Lifeline Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Lifeline Co ranks #142 out of 847 companies for 3-1 Month Momentum %. This places Japan Lifeline Co in the top 17% of its industry — outperforming the majority of peers. The industry median 3-1 Month Momentum % is 0.61. Japan Lifeline Co's value of 17.37% is 2747.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.61, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Lifeline Co's current 3-1 Month Momentum % of 17.37% is 2747.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Japan Lifeline Co and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Lifeline Co's current 3-1 Month Momentum % is 17.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Lifeline Co (TSE:7575) is currently considered Fairly Valued. The stock's GF Value™ is 円1,555.58, compared to a current price of 円1,575.00 — trading 1.2% above its estimated fair value. The current 3-1 Month Momentum % is 17.37% and 2747.5% above the Medical Devices & Instruments industry median of 0.61. Japan Lifeline Co's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Japan Lifeline Co (TSE:7575), the current 3-1 Month Momentum % is 17.37% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (TSE:7575) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be overvalued.
The current stock price of 円1,575.00 is trading 1.2% above its estimated GF Value™ of 円1,555.58.
GuruFocus considers Japan Lifeline Co to be Fairly Valued.
Key valuation signals for TSE:7575:
3-1 Month Momentum %: 17.37%
GF Value™: 円1,555.58 vs. price of 円1,575.00 (1.2% above fair value)
Industry Position: 2747.5% above the Medical Devices & Instruments median (#142 of 847)
No single metric tells the full story. See the TSE:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
90GF Score
Get the complete analysis for TSE:7575
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7575 has been successfully added to your 
